Overview

A Study Investigating the Concentrations of Darapladib in Blood and the Safety of This Compound in Healthy Japanese Men

Status:
Completed
Trial end date:
2007-09-01
Target enrollment:
Participant gender:
Summary
This study is being conducted to provide initial safety, tolerability, PK and PD data that will allow further studies with darapladib in Japanese patients
Phase:
Phase 1
Details
Lead Sponsor:
GlaxoSmithKline
Treatments:
Darapladib